🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchOrforglipron ATTAIN-4 — my results so far Page 8

Orforglipron ATTAIN-4 — my results so far

roxy_nash Sat, Jul 12, 2025 at 6:46 AM 43 replies 2,076 viewsPage 8 of 9
wei_SG
Member
234
890
Nov 2024
Singapore, SG
Dec 27, 2025 at 2:00 PM#36
labquiet_amy said:
One practical note: write down what you did and when, before you need it.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The counter-case has not been addressed. Somebody upthread described the situation that does not fit, and the thread moved on rather than engaging with it, which is the failure mode this board is supposed to avoid.

26 24WendyG_ATL, SaraMom3, Dr.MetabolicMD and 23 others
Reply Quote Save Share Report
mike.trainer_LA
Senior Member
1,567
7,234
Apr 2024
Los Angeles, CA
Jan 6, 2026 at 7:08 AM#37
labquiet_amy said:
One practical note: write down what you did and when, before you need it.

Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.

I would rather be corrected than agreed with, if it comes to it.

27 0newstart_MO, mia_MS2, LeilaHI and 24 others
Reply Quote Save Share Report
carl_compliance
Member
234
1,123
Nov 2024
Raleigh, NC
Jan 16, 2026 at 12:22 AM#38
labquiet_amy said:
One practical note: write down what you did and when, before you need it.

Genuinely useful, thank you. I had the facts and not the framework. Sending this to two other people who asked me the same thing last week.

28 1ricardo_MIA, BrianDallas92, labquiet_amy and 25 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.NutriCornell
Senior Member
1,345
6,234
Mar 2024
Ithaca, NY
Jan 25, 2026 at 5:41 PM#39

Adding the clinical framing, because it changes how the question reads. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

29 2JenMemphis, pat_auckland, Dr.GastroMayo and 26 others
Reply Quote Save Share Report
quinn_sf
Member
489
2,123
Jun 2024
San Francisco, CA
Feb 4, 2026 at 11:06 AM#40
Dr.NutriCornell said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

Same experience, arrived at from the opposite direction. I had assumed I was the exception until I read this.

Last edited: Feb 4, 2026 at 5:06 PM
1 24Dr.EndoEP
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register